Product Information
CEFPROZIL 250 MG/5 ML SUSP is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1470 per ML under NDC 57237003501. Its NADAC has been published 646 times since Apr 9, 2014.
FDA first approved this application on Jan 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/5mL
Manufacturer
Rising Pharma Holdings Inc.NDC
57237003501
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFPROZILApproval Type
Generic (ANDA)
FDA Application
ANDA065381FDA Approved
1/30/2007
TE Code
AB
On Market Since
1/30/2007
Price Statistics
The NADAC for CEFPROZIL 250 MG/5 ML SUSP has been published 646 times since Apr 9, 2014, and over the history we have for it it has declined 73.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1470 per ML |
|---|---|
| All-time high | $0.5585 (Jul 16, 2014) |
| All-time low | $0.1204 (Jul 17, 2024) |
| 52-week high | $0.1792 |
| 52-week low | $0.1377 |
| Median price | $0.2404 |
| Average price | $0.2958 |
| Largest weekly change | +104.7% (Nov 18, 2020) |
| Weeks tracked | 646 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFPROZIL 250 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 250 MG/5 ML SUSP, manufactured by Rising Pharma Holdings Inc., is $0.1470 per ML (NDC 57237003501), effective Aug 19, 2026.
How has the price of CEFPROZIL 250 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFPROZIL 250 MG/5 ML SUSP has declined 73.2%. It has been tracked across 646 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for CEFPROZIL 250 MG/5 ML SUSP?
Since Apr 9, 2014, the NADAC for CEFPROZIL 250 MG/5 ML SUSP has ranged from a low of $0.1204 (Jul 17, 2024) to a high of $0.5585 (Jul 16, 2014), with a median of $0.2404 per ML.
Are there cheaper alternatives to CEFPROZIL 250 MG/5 ML SUSP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFPROZIL 250 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFPROZIL 250 MG/5 ML SUSP?
CEFPROZIL 250 MG/5 ML SUSP (NDC 57237003501) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.